Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 22.32 USD -3% Market Closed
Market Cap: 4.1B USD

Wall Street
Price Targets

LEGN Price Targets Summary
Legend Biotech Corp

Wall Street analysts forecast LEGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LEGN is 74.95 USD with a low forecast of 53.65 USD and a high forecast of 95.55 USD.

Lowest
Price Target
53.65 USD
140% Upside
Average
Price Target
74.95 USD
236% Upside
Highest
Price Target
95.55 USD
328% Upside
Legend Biotech Corp Competitors:
Price Targets
GILD
Gilead Sciences Inc
11% Upside
214450
PharmaResearch Co Ltd
94% Upside
RNA
Avidity Biosciences Inc
3% Upside
TWST
Twist Bioscience Corp
27% Upside
PHIL
Philogen SpA
14% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
35% Upside
CCCC
C4 Therapeutics Inc
390% Upside
4974
Takara Bio Inc
42% Upside

Revenue
Forecast

Revenue Estimate
Legend Biotech Corp

For the last 6 years the compound annual growth rate for Legend Biotech Corp's revenue is 53%. The projected CAGR for the next 4 years is 43%.

53%
Past Growth
43%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Legend Biotech Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Legend Biotech Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LEGN's stock price target?
Price Target
74.95 USD

According to Wall Street analysts, the average 1-year price target for LEGN is 74.95 USD with a low forecast of 53.65 USD and a high forecast of 95.55 USD.

What is Legend Biotech Corp's Revenue forecast?
Projected CAGR
43%

For the last 6 years the compound annual growth rate for Legend Biotech Corp's revenue is 53%. The projected CAGR for the next 4 years is 43%.

Back to Top